|
Scientists find new agent to fight genetic disorders -- Zorro-Locked Nucleic Acid
April 30, 2007A study to appear in the June 2007 issue of The FASEB Journal describes a new agent, called "Zorro-LNA," which has the potential to stop genetic disorders in their tracks. In the study, researchers from the Karolinska Institute in Stockholm, Sweden, describe how they developed Zorro-LNA to bind with both strands of a gene's DNA simultaneously, effectively disabling that gene. This development has clinical implications for virtually every human condition caused by or worsened by dominant defective genes. Examples include: Huntington's disease, familial high cholesterol, polycystic kidney disease, some instances of glaucoma and colorectal cancer, and neurofibromatosis, among others.
"Zorro-LNA is a new substance that targets DNA and turns off genes," said co-author Edvard Smith of the Karolinska Institute in Sweden. "It has the potential of becoming a new drug for the treatment of human genetic disease."
The findings described in this article significantly raise the possibility that new therapies could arise where defective DNA is deactivated more completely and more thoroughly than ever before. For instance, Zorro-LNA could be used in combination with "RNA interference" (RNAi). Like Zorro-LNA, RNAi has the ability to deactivate genes, but does so by degrading the gene's RNA. In addition, Zorro-LNA could be used to deactivate certain genes in stem cells, which could eventually lead to the development of new cells, tissues, or organs. The discovery of RNAi was recognized by a Nobel Prize award in 2006 to two American scientists.
"This is a major development in the treatment not only of genetic diseases, but also of acquired diseases when microbes or toxins cause genes to go awry" said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "One might say these researchers have found a gene-hunter's Holy Grail for which scientists have been hunting for many years. Zorro-LNA should give us a new, safe way of blocking the effects of errors in our genetic repertoire."
Federation of American Societies for Experimental Biology
"This is a major development in the treatment not only of genetic diseases, but also of acquired diseases when microbes or toxins cause genes to go awry" said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "One might say these researchers have found a gene-hunter's Holy Grail for which scientists have been hunting for many years. Zorro-LNA should give us a new, safe way of blocking the effects of errors in our genetic repertoire."
Federation of American Societies for Experimental Biology
Nucleic Acid News and Current Nucleic Acid Events RSSGenome sequence of lancelet shows how genes quadrupled during vertebrate evolution
The newly sequenced genome of a dainty, quill-like sea creature called a lancelet provides the best evidence yet that vertebrates evolved over the past 550 million years through a four-fold duplication of the genes of more primitive ancestors.
Simple membranes could have allowed nutrients to pass into primitive cells
When the first cells developed, how could they bring molecules from the environment into their living interior without the specialized structures found on the modern cell membrane?
New vaccine approach prevents/reverses diabetes in lab study at Children's Hospital of Pittsburgh
Microspheres carrying targeted nucleic acid molecules fabricated in the laboratory have been shown to prevent and even reverse new-onset cases of type 1 diabetes in animal models. The results of these studies were reported by diabetes researchers at the John G. Rangos Sr. Research Center at Children's Hospital of Pittsburgh of UPMC and Baxter Healthcare Corporation.
DNA fingerprinting simplified
Agarose gel electrophoresis" Most teenagers wouldn't have a clue what this scientific term means, but middle school student Andrew Trigiano knows the protocol inside and out. When Andrew was 12, his father Robert Trigiano, a professor at the University of Tennessee, was looking for an interesting science project for his son.
Herpes virus link to complications in pregnancy
Researchers at Adelaide's Women's & Children's Hospital and the University of Adelaide, Australia, have made a world-first discovery that links viral infection with high blood pressure during pregnancy and pre-term birth.
Stanford researchers make first direct observation of 3-D molecule folding in real time
All the crucial proteins in our bodies must fold into complex shapes to do their jobs. These snarled molecules grip other molecules to move them around, to speed up important chemical reactions or to grab onto our genes, turning them "on" and "off" to affect which proteins our cells make.
Nanotechnology innovation may revolutionize gene detection in a single cell
Scientists at Arizona State University's Biodesign Institute have developed the world's first gene detection platform made up entirely from self-assembled DNA nanostructures.
New clinical trial results show how personalized medicine will alter treatment of genetic disorders
One of the nation's pre-eminent genetic researchers, Eric Hoffman, PhD, of Children's Research Institute at Children's National Medical Center, predicts that in relatively short order, medicine's next innovation--individualized molecular therapies--will have the unprecedented ability to treat muscular dystrophies, and other disorders.
MCG selected as RNA laboratory for worldwide diabetes study
The Medical College of Georgia Center for Biotechnology and Genomic Medicine has been selected to isolate RNA and DNA from the blood of thousands of children involved in a worldwide study of the causes of type 1 diabetes.
Silencing small but mighty cancer inhibitors
Researchers from Johns Hopkins and the University of Pennsylvania have uncovered another reason why one of the most commonly activated proteins in cancer is in fact so dangerous.
More Nucleic Acid News Articles
 | Molecular Diagnostics: Fundamentals, Methods, & Clinical Applications by Lela, Ph.D. Buckingham, Maribeth L., Ph.D. Flaws |
 | Biological Sequence Analysis: Probabilistic Models of Proteins and Nucleic Acids by Richard Durbin, Sean R. Eddy, Anders Krogh, Graeme Mitchison |
 | A-Z of Quantitative PCR (IUL Biotechnology, No. 5) (Iul Biotechnology Series) |
 | The Expanding Role of Mass Spectrometry in Biotechnology, Second Edition by Gary Siuzdak |
 | Practical in Situ Hybridization by Trude Schwarchzacher, Pat Heslop-Harrison |
 | Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules (Medical Intelligence Unit) by Christopher G. Janson, Matthew J. During |
 | Plant Virology Protocols: From Viral Sequence to Protein Function (Methods in Molecular Biology) |
| In Search of the Double Helix: Quantum Physics and Life by John Gribbin | |
 | Nucleic Acids in Chemistry and Biology |
 | Mass Spectrometry for Biotechnology by Gary Siuzdak |
| © 2008 BrightSurf.com |